摘要
目的了解鲍曼不动杆菌的临床分布情况及耐药特点。方法分析我院2008年2月-2009年10月静脉血标本中检出鲍曼不动杆菌的住院患者治疗情况,对鲍曼不动杆菌的科室分布、伴发病原菌情况进行统计学分析;并按临床经验用药与药敏结果是否相符分为两组,各7例;比较两组的治疗有效率。结果重症监护室送检标本阳性率占40.91%,肝胆外科占22.73%;药敏试验显示,鲍曼不动杆菌对头孢哌酮/舒巴坦耐药率最低(47.6%),其次是氨苄西林/舒巴坦(72.7%)、亚胺培南和美罗培南(81.8%)。相符组有效率85.71%;不符组有效率57.14%。结论鲍曼不动杆菌感染常见于重症监护室;根据药敏结果用药,对指导临床治疗鲍曼不动杆菌具有重要意义。
Objective To understand clinical distribution and drug-resistance features of Acinetobacter baumannii.Methods We analysed the treatment of Acinetobacter baumannii from venous blood specimen of the hospitalized patients in our hospital from February 2008 to October 2009 and the distribution of department and pathogen of Acinetobacter baumannii statistically.As the empirical treatment coincided with drug sensitivity results or not,specimen were divided into 2 groups and the cure rate was compared.Results The positive rates of specimen from intensive care unit and department of hepatobiliary surgery were 40.91% and 22.73% respectively.The drug sensitive test showed the resistance rates of Cefoperazone/Sulbactam,Ampicillin/Sullbactam,Imipenem and Meropenem to Acinetobacter baumannii were 47.6%,72.7% and 81.8% separately.7 empirical treatment agreed with drug sensitivity results and the effective rate was 85.71%;7 empirical treatment didn′t agree with drug sensitivity results and the effective rate was 57.14%.Conclusion Acinetobacter baumannii was common in intensive care unit.If treatment was on the basis of drug sensitivity results,it was of significance to the clinical treatment of Acinetobacter baumannii.
出处
《军医进修学院学报》
CAS
2011年第6期604-606,共3页
Academic Journal of Pla Postgraduate Medical School
关键词
鲍曼不动杆菌
血培养
耐药
Acinetobacter Baumannii
Hemoculture
Drug Resistance
